“Sglt-2 Inhibitors in Diabetic Type 2 Patients Nephroprotective Effects of (Empagliflozin)”. 2023. Eurasian Journal of Research, Development and Innovation 26 (November): 1-4. https://geniusjournals.org/index.php/ejrdi/article/view/5178.